The influence of the microbiome on type 1 diabetes

Journal of Immunology

Volumn 198, Issue 2, 2017, Pages 590-595

  Paun, Alexandra ^a   Yau, Christopher ^a,b   Danska, Jayne S ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; AUTOIMMUNITY; BIOLOGICAL MODEL; COHORT ANALYSIS; COMMENSAL; ENDOCRINE PANCREAS; ENVIRONMENTAL FACTOR; GENDER; HUMAN; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; LIFESTYLE; LONGITUDINAL STUDY; METABOLITE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MUCOSAL IMMUNITY; NONHUMAN; PHYSIOLOGY; REVIEW; RISK FACTOR; RODENT MODEL; SPECIES COMPOSITION; THERAPY EFFECT; ANIMAL; IMMUNOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 1; GASTROINTESTINAL MICROBIOME; HUMANS;

EID: 85014664265     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601519     Document Type: Review

References (57)

1. Nerup, J., P. Platz, O. O. Andersen, M. Christy, J. Lyngsoe, J. E. Poulsen, L. P. Ryder, L. S. Nielsen, M. Thomsen, and A. Svejgaard. 1974. HL-A antigens and diabetes mellitus. Lancet 2: 864-866
2. Cudworth, A. G., and J. C. Woodrow. 1974. Letter: HL-A antigens and diabetes mellitus. Lancet 2: 1153
3. Thayer, T. C., S. B. Wilson, and C. E. Mathews. 2010. Use of nonobese diabetic mice to understand human type 1 diabetes. Endocrinol.Metab. Clin. North Am. 39: 541-561
4. Acha-Orbea, H., and H. O. McDevitt. 1987. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc. Natl. Acad. Sci. USA 84: 2435-2439
5. Todd, J. A., J. I. Bell, and H. O. McDevitt. 1987. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604
6. Barrett, J. C., D. G. Clayton, P. Concannon, B. Akolkar, J. D. Cooper, H. A. Erlich, C. Julier, G. Morahan, J. Nerup, C. Nierras, et al. 2009. Genomewide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 41: 703-707
7. Concannon, P., S. S. Rich, and G. T. Nepom. 2009. Genetics of type 1A diabetes. N. Engl. J. Med. 360: 1646-1654
8. Wicker, L. S., J. Clark, H. I. Fraser, V. E. Garner, A. Gonzalez-Munoz, B. Healy, S. Howlett, K. Hunter, D. Rainbow, R. L. Rosa, et al. 2005. Type 1 diabetes genes and pathways shared by humans and NOD mice. J. Autoimmun. 25(Suppl): 29-33
9. Bingley, P. J., and E. A. Gale. 1989. Rising incidence of IDDM in Europe. Diabetes Care 12: 289-295
10. Kurtz, Z., C. S. Peckham, and A. E. Ades. 1988. Changing prevalence of juvenileonset diabetes mellitus. Lancet 2: 88-90
11. Gale, E. A. 2002. The rise of childhood type 1 diabetes in the 20th century. Diabetes 51: 3353-3361
12. Onkamo, P., S. Vaänänen, M. Karvonen, and J. Tuomilehto. 1999. Worldwide increase in incidence of Type I diabetes-the analysis of the data on published incidence trends. Diabetologia 42: 1395-1403
13. Krischer, J. P., K. F. Lynch, D. A. Schatz, J. Ilonen, A . Lernmark, W. A. Hagopian, M. J. Rewers, J. X. She, O. G. Simell, J. Toppari, et al. 2015. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 58: 980-987
14. Vatanen, T., A. D. Kostic, E. d'Hennezel, H. Siljander, E. A. Franzosa, M. Yassour, R. Kolde, H. Vlamakis, T. D. Arthur, A. M. Hämäläinen, et al. 2016. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. [Published erratum appears in 2016 Cell 165: 1551.] Cell 165: 842-853
15. Hooper, L. V., D. R. Littman, and A. J. Macpherson. 2012. Interactions between the microbiota and the immune system. Science 336: 1268-1273
16. Todd, J. A., and L. S. Wicker. 2001. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15: 387-395
17. Wicker, L. S., J. A. Todd, and L. B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13: 179-200
18. Ghosh, S., S. M. Palmer, N. R. Rodrigues, H. J. Cordell, C. M. Hearne, R. J. Cornall, J. B. Prins, P. McShane, G. M. Lathrop, L. B. Peterson, et al. 1993. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat. Genet. 4: 404-409
19. Miao, D., L. Yu, and G. S. Eisenbarth. 2007. Role of autoantibodies in type 1 diabetes. Front. Biosci. 12: 1889-1898
20. Pozzilli, P., A. Signore, A. J. Williams, and P. E. Beales. 1993. NOD mouse colonies around the world-recent facts and figures. Immunol. Today 14: 193-196
21. Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347: 911-920
22. Wen, L., R. E. Ley, P. Y. Volchkov, P. B. Stranges, L. Avanesyan, A. C. Stonebraker, C. Hu, F. S. Wong, G. L. Szot, J. A. Bluestone, et al. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113
23. Burrows, M. P., P. Volchkov, K. S. Kobayashi, and A. V. Chervonsky. 2015. Microbiota regulates type 1 diabetes through Toll-like receptors. Proc. Natl. Acad. Sci. USA 112: 9973-9977
24. Markle, J. G., D. N. Frank, S. Mortin-Toth, C. E. Robertson, L. M. Feazel, U. Rolle-Kampczyk, M. von Bergen, K. D. McCoy, A. J. Macpherson, and J. S. Danska. 2013. Sex differences in the gut microbiome drive hormonedependent regulation of autoimmunity. Science 339: 1084-1088
25. Yurkovetskiy, L., M. Burrows, A. A. Khan, L. Graham, P. Volchkov, L. Becker, D. Antonopoulos, Y. Umesaki, and A. V. Chervonsky. 2013. Gender bias in autoimmunity is influenced by microbiota. Immunity 39: 400-412
26. Loo, V. G., A. M. Bourgault, L. Poirier, F. Lamothe, S. Michaud, N. Turgeon, B. Toye, A. Beaudoin, E. H. Frost, R. Gilca, et al. 2011. Host and pathogen factors for Clostridium difficile infection and colonization. N. Engl. J. Med. 365: 1693-1703
27. Hensgens, M. P., E. C. Keessen, M. M. Squire, T. V. Riley, M. G. Koene, E. de Boer, L. J. Lipman, and E. J. Kuijper; European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD). 2012. Clostridium difficile infection in the community: a zoonotic disease Clin. Microbiol. Infect. 18: 635-645
28. Candon, S., A. Perez-Arroyo, C. Marquet, F. Valette, A. P. Foray, B. Pelletier, C. Milani, M. Ventura, J. F. Bach, and L. Chatenoud. 2015. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. [Published erratum appears in 2016 PLoS One 11: e0147888.] PLoS One 10: e0125448
29. Livanos, A. E., T. U. Greiner, P. Vangay, W. Pathmasiri, D. Stewart, S. McRitchie, H. Li, J. Chung, J. Sohn, S. Kim, et al. 2016. Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nat. Microbiol. 1: 16140
30. Sun, J., L. Furio, R. Mecheri, A. M. van der Does, E. Lundeberg, L. Saveanu, Y. Chen, P. van Endert, B. Agerberth, and J. Diana. 2015. Pancreatic b-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 43: 304-317
31. Koenig, J. E., A. Spor, N. Scalfone, A. D. Fricker, J. Stombaugh, R. Knight, L. T. Angenent, and R. E. Ley. 2011. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. USA 108(Suppl 1): 4578-4585
32. Dominguez-Bello, M. G., E. K. Costello, M. Contreras, M. Magris, G. Hidalgo, N. Fierer, and R. Knight. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA 107: 11971-11975
33. Palmer, C., E. M. Bik, D. B. DiGiulio, D. A. Relman, and P. O. Brown. 2007. Development of the human infant intestinal microbiota. PLoS Biol. 5: e177
34. Cox, L. M., S. Yamanishi, J. Sohn, A. V. Alekseyenko, J. M. Leung, I. Cho, S. G. Kim, H. Li, Z. Gao, D. Mahana, et al. 2014. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158: 705-721
35. Kimpimäki, T., A. Kupila, A. M. Hämäläinen, M. Kukko, P. Kulmala, K. Savola, T. Simell, P. Keskinen, J. Ilonen, O. Simell, and M. Knip. 2001. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the finnish Type 1 diabetes prediction and prevention study. J. Clin. Endocrinol. Metab. 86: 4782-4788
36. Ziegler, A. G., and E. Bonifacio; BABYDIAB-BABYDIET Study Group. 2012. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 55: 1937-1943
37. Parikka, V., K. Näntö-Salonen, M. Saarinen, T. Simell, J. Ilonen, H. Hyöty, R. Veijola, M. Knip, and O. Simell. 2012. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 55: 1926-1936
38. Ziegler, A. G., and G. T. Nepom. 2010. Prediction and pathogenesis in type 1 diabetes. Immunity 32: 468-478
39. DIAMOND Project Group. 2006. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet. Med. 23: 857-866
40. Rønningen, K. S., N. Keiding, and A. Green; Genomic Marker Contributors; EURODIAB ACE Study Group. 2001. Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia 44: B51-B59
41. Vaarala, O. 2006. Is it dietary insulin Ann. N. Y. Acad. Sci. 1079: 350-359
42. Knip, M., S. M. Virtanen, K. Seppä, J. Ilonen, E. Savilahti, O. Vaarala, A. Reunanen, K. Teramo, A. M. Hämäläinen, J. Paronen, et al. 2010. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N. Engl. J. Med. 363: 1900-1908
43. Vaarala, O., J. Ilonen, T. Ruohtula, J. Pesola, S. M. Virtanen, T. Härkönen, M. Koski, H. Kallioinen, O. Tossavainen, T. Poussa, et al. 2012. Removal of bovine insulin from cow's milk formula and early initiation of beta-cell autoimmunity in the FINDIA pilot study. Arch. Pediatr. Adolesc. Med. 166: 608-614
44. de Goffau, M. C., K. Luopajärvi, M. Knip, J. Ilonen, T. Ruohtula, T. Härkönen, L. Orivuori, S. Hakala, G. W. Welling, H. J. Harmsen, and O. Vaarala. 2013. Fecal microbiota composition differs between children with b-cell autoimmunity and those without. Diabetes 62: 1238-1244
45. Smigoc Schweiger, D., A. Mendez, S. Kunilo Jamnik, N. Bratanic, N. Bratina, T. Battelino, J. Brecelj, and B. Vidan-Jeras. 2016. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease. Autoimmunity 49: 240-247
46. Gruhn, M., P. Rosenbaum, H. P. Bollhagen, and A. Bueschges. 2011. Studying the neural basis of adaptive locomotor behavior in insects. J. Vis. Exp. (50):2629
47. Endesfelder, D., W. zu Castell, A. Ardissone, A. G. Davis-Richardson, P. Achenbach, M. Hagen, M. Pflueger, K. A. Gano, J. R. Fagen, J. C. Drew, et al. 2014. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63: 2006-2014
48. Hagopian, W. A., H. Erlich, A. Lernmark, M. Rewers, A. G. Ziegler, O. Simell, B. Akolkar, R. Vogt, Jr., A. Blair, J. Ilonen, et al. 2011. The environmental determinants of diabetes in the young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr. Diabetes 12: 733-743
49. Kemppainen, K. M., A. N. Ardissone, A. G. Davis-Richardson, J. R. Fagen, K. A. Gano, L. G. León-Novelo, K. Vehik, G. Casella, O. Simell, A. G. Ziegler, et al. 2015. Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care 38: 329-332
50. Davis-Richardson, A. G., A. N. Ardissone, R. Dias, V. Simell, M. T. Leonard, K. M. Kemppainen, J. C. Drew, D. Schatz, M. A. Atkinson, B. Kolaczkowski, et al. 2014. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front. Microbiol. 5: 678
51. Leonard, M. T., A. G. Davis-Richardson, A. N. Ardissone, K. M. Kemppainen, J. C. Drew, J. Ilonen, M. Knip, O. Simell, J. Toppari, R. Veijola, et al. 2014. The methylome of the gut microbiome: disparate Dam methylation patterns in intestinal Bacteroides dorei. Front. Microbiol. 5: 361
52. Heusipp, G., S. Fälker, and M. A. Schmidt. 2007. DNA adenine methylation and bacterial pathogenesis. Int. J. Med. Microbiol. 297: 1-7
53. Kondrashova, A., T. Seiskari, J. Ilonen, M. Knip, and H. Hyöty. 2013. The 'Hygiene hypothesis' and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland. APMIS 121: 478-493
54. Kostic, A. D.,D.Gevers,H. Siljander, T.Vatanen, T.Hyötyläinen, A.-M. Hämäläinen, A. Peet, V. Tillmann, P. Pöhö, I.Mattila, et al. 2015. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17: 260-273
55. Uusitalo, U., X. Liu, J. Yang, C. A. Aronsson, S. Hummel, M. Butterworth, A . Lernmark, M. Rewers, W. Hagopian, J. X. She, et al 2016. Association of early exposure of probiotics and islet autoimmunity in the TEDDY study. JAMA Pediatr. 170: 20-28
56. Hooper, L. V., and A. J. Macpherson. 2010. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10: 159-169
57. Gomez de Agüero, M., S. C. Ganal-Vonarburg, T. Fuhrer, S. Rupp, Y. Uchimura, H. Li, A. Steinert, M. Heikenwalder, S. Hapfelmeier, U. Sauer, et al. 2016. The maternal microbiota drives early postnatal innate immune development. Science 351: 1296-1302.